8021 - 8030 of 8586 Results
Title
Year
- Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease2014RESTRICTEDTitle: Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s diseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 265Issue #:Start Page: 245End Page: 252Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.01.042Citation Count: 36
- A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons2017OPENTitle: A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal InterneuronsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 2Start Page: 306End Page: 319Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00329Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5924706Citation Count: 50
- Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implications2025OPENTitle: Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implicationsJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol:Issue #:Start Page: jnnpEnd Page: 335364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2024-335364Best OA location URL: https://doi.org/10.1136/jnnp-2024-335364Citation Count: 2
- Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter study2017RESTRICTEDTitle: Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter studyJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1335End Page: 1336Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27092Citation Count: 13
-
OPENTitle: Neurogenesis in Cancun: where science meets the seaJournal Name: DevelopmentPublisher: The Company of BiologistsVol: 143Issue #: 10Start Page: 1649End Page: 1654Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/dev.138412Best OA location URL: https://journals.biologists.com/dev/article-pdf/143/10/1649/1842172/dev138412.pdfCitation Count: 0
-
OPENTitle: Biallelic variants in ZNF142 lead to a syndromic neurodevelopmental disorderJournal Name: Clinical GeneticsPublisher: WileyVol: 102Issue #: 2Start Page: 98End Page: 109Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1111/cge.14165Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cge.14165Citation Count: 14
-
OPENTitle: Neuromelanin accumulation drives endogenous synucleinopathy in non-human primatesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 12Start Page: 5000End Page: 5014Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/brain/awad331Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad331/51792215/awad331.pdfCitation Count: 16
- Perceptual consequences of online group speech treatment for individuals with Parkinson’s disease: A pilot study case series2024RESTRICTEDTitle: Perceptual consequences of online group speech treatment for individuals with Parkinson’s disease: A pilot study case seriesJournal Name: International Journal of Speech-Language PathologyPublisher: Informa UK LimitedVol: 27Issue #: 2Start Page: 1End Page: 16Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/17549507.2024.2330538Citation Count: 5
- The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study2015RESTRICTEDTitle: The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography studyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 4Start Page: 1736End Page: 1742Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.12.037Citation Count: 44
- G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-22023OPENTitle: G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2Journal Name: BiomoleculesPublisher: MDPI AGVol: 13Issue #: 3Start Page: 473End Page: 473Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom13030473Best OA location URL: https://www.mdpi.com/2218-273X/13/3/473/pdf?version=1677847463Citation Count: 2